Gastroenterology
Volume 137, Issue 5 , Pages 1746-1756.e1 , November 2009

An FcRn-Dependent Role for Anti-flagellin Immunoglobulin G in Pathogenesis of Colitis in Mice

  • Kanna Kobayashi

      Affiliations

    • Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Shuo–Wang Qiao

      Affiliations

    • Rikshospitalet University Hospital, Oslo, Norway
    • ,
  • Masaru Yoshida

      Affiliations

    • Gastrointestinal Center for Medical Research, Kobe University School of Medicine, Kobe, Japan
    • ,
  • Kristi Baker

      Affiliations

    • Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Wayne I. Lencer

      Affiliations

    • Gastroenterology Division, Children's Hospital Boston, Harvard Medical School, Boston Massachusetts
    • ,
  • Richard S. Blumberg

      Affiliations

    • Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationReprint requests Address requests for reprints to: Richard S. Blumberg, MD, Gastroenterology Division, Brigham and Women's Hospital, 75 Francis St, Boston, Massachusetts 02115. fax: (617) 264-5185

Received 12 May 2009 ,Accepted 22 July 2009.

References 

  1. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002;20:495–549
  2. Sutherland L, Singleton J, Sessions J, et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut. 1991;32:1071–1075
  3. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458–466
  4. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008;134:743–756
  5. Onderdonk AB, Hermos JA, Bartlett JG. The role of the intestinal microflora in experimental colitis. Am J Clin Nutr. 1977;30:1819–1825
  6. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577–594
  7. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn's disease. J Clin Invest. 2004;113:1296–1306
  8. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689–699
  9. MacDermott RP, Nash GS, Bertovich MJ, et al. Alterations of IgM, IgG, and IgA synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. Gastroenterology. 1981;81:844–852
  10. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, et al. IBD serological panels: facts and perspectives. Inflamm Bowel Dis. 2007;13:1561–1566
  11. Mizoguchi A, Mizoguchi E, Tonegawa S, et al. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCRα mutant mice with inflammatory bowel disease. Int Immunol. 1996;8:1387–1394
  12. Brandwein SL, McCabe RP, Cong Y, et al. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol. 1997;159:44–52
  13. Brandtzaeg P, Halstensen TS, Kett K, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology. 1989;97:1562–1584
  14. Sitaraman SV, Klapproth JM, Moore DA, et al. Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2005;288:G403–G406
  15. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128:2020–2028
  16. Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol. 2007;7:715–725
  17. Mi W, Wanjie S, Lo ST, et al. Targeting the neonatal Fc receptor for antigen delivery using engineered Fc fragments. J Immunol. 2008;181:7550–7561
  18. Rodewald R. pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat. J Cell Biol. 1976;71:666–669
  19. Dickinson BL, Badizadegan K, Wu Z, et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest. 1999;104:903–911
  20. Yoshida M, Claypool SM, Wagner JS, et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity. 2004;20:769–783
  21. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the β 2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A. 1996;93:5512–5516
  22. Roopenian DC, Christianson GJ, Sproule TJ, et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol. 2003;170:3528–3533
  23. Akilesh S, Christianson GJ, Roopenian DC, et al. Neonatal FcR expression in bone marrow-derives cells functions to protect serum IgG from catabolism. J Immunol. 2007;179:4580–4588
  24. Qiao SW, Kobayashi K, Johansen FE, et al. Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A. 2008;105:9337–9342
  25. ten Hove T, van den Blink B, Pronk I, et al. Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis. Gut. 2002;50:507–512
  26. Tsuchiya T, Fukuda S, Hamada H, et al. Role of δγT cells in the inflammatory response of experimental colitis mice. J Immunol. 2003;171:5507–5513
  27. Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature. 1989;337:184–187
  28. Yoshida M, Kobayashi K, Kuo TT, et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest. 2006;116:2142–2151
  29. Zhu X, Meng G, Dickinson BL, et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol. 2001;166:3266–3276
  30. Ye L, Liu X, Rout SN, et al. The MHC class II-associated invariant chain interacts with the neonatal Fcγ receptor and modulates its trafficking to endosomal/lysosomal compartments. J Immunol. 2008;181:2572–2585
  31. Akilesh S, Petkova S, Sproule TJ, et al. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest. 2004;113:1328–1333
  32. Shintani N, Nakajima T, Nakakubo H, et al. Intravenous immunoglobulin (IVIG) treatment of experimental colitis induced by dextran sulfate sodium in rats. Clin Exp Immunol. 1997;108:340–345
  33. Levine DS, Fischer SH, Christie DL, et al. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis. Am J Gastroenterol. 1992;87:91–100
  34. Liu L, Garcia AM, Santoro H, et al. Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade. J Immunol. 2007;178:5390–5398
  35. Vaccaro C, Zhou J, Ober RJ, et al. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol. 2005;23:1283–1288
  36. Mezo AR, McDonnell KA, Hehir CA, et al. Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc Natl Acad Sci U S A. 2008;105:2337–2342
  37. Rhee SH, Im E, Riegler M, et al. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci U S A. 2005;102:13610–13615
  38. Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest. 2007;117:3909–3921
  39. Axelsson LG, Landstrom E, Goldschmidt TJ, et al. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4+-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res. 1996;45:181–191
  40. Israel EJ, Taylor S, Wu Z, et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology. 1997;92:69–74

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by NIH DK53056 and the Harvard Digestive Diseases Center (DK034854) (to R.S.B. and W.I.L.), by NIH DK44319 and DK51362 (to R.S.B.), and by Crohn's and Colitis Foundation of America (to W.I.L.).

PII: S0016-5085(09)01382-1

doi: 10.1053/j.gastro.2009.07.059

Gastroenterology
Volume 137, Issue 5 , Pages 1746-1756.e1 , November 2009

Article Tools

* Image Usage & Resolution